Cross Country Healthcare, Inc.
CCRN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.34 | -0.18 | 0.13 | -0.01 |
| FCF Yield | 18.38% | 29.46% | 12.74% | -9.11% |
| EV / EBITDA | 132.43 | 6.06 | 3.99 | 7.96 |
| Quality | ||||
| ROIC | -3.18% | 14.92% | 29.52% | 25.31% |
| Gross Margin | 20.41% | 22.30% | 22.36% | 22.37% |
| Cash Conversion Ratio | -8.25 | 3.42 | 0.72 | -0.65 |
| Growth | ||||
| Revenue 3-Year CAGR | -21.73% | 6.40% | 49.65% | 26.81% |
| Free Cash Flow Growth | -52.50% | 87.22% | 235.00% | -510.77% |
| Safety | ||||
| Net Debt / EBITDA | -19.49 | -0.09 | 0.54 | 1.28 |
| Interest Coverage | -7.71 | 13.93 | 18.98 | 20.29 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 196.88 | 170.20 |
| Cash Conversion Cycle | 64.00 | 69.47 | 85.53 | 79.99 |